This is a rare health-behavior app with exceptional fundamentals: $3.9K monthly profit (83% margin) at just 1.54x annual profit multiple — well below SaaS benchmarks. Verified financials, 19-month operating history, and a founder with authentic domain expertise (ex-snus user building for personal pain point). The dual-platform native build and 83% margin signal either lean ops or genuine product-market fit. Primary acquisition risk is undisclosed user count, retention cohorts, and whether growth is organic or paid-driven; however, the financial transparency and valuation multiple more than compensate.
Building a native dual-platform (iOS+Android) health-tracking app from scratch with backend and app-store compliance requires 16+ weeks and $8K–$18K in AI-assisted dev costs (Cursor/Claude subscriptions, managed hosting, third-party health APIs). However, the acquisition case rests overwhelmingly on verified cash flow ($3.9K/mo profit) and the founder's validated domain expertise in a niche health behavior (ex-snus user). The 83% margin and authentic design (not 'AI slop') suggest real users with genuine retention and engagement, which a fresh build cannot replicate without the same founder and market entry cost. Software reproducibility is moderate (health trackers are structurally simple), but the installed user base, app-store rating/review history, and operational playbook are non-trivial assets. At 1.54x profit multiple, you are buying 14 months of payback at current run rate plus the distribution footprint and founder knowledge; the build alternative requires 4+ months of calendar time plus founder sweat and post-launch acquisition spend. Verdict favors acquisition at this valuation and margin profile, contingent on due-diligence verification of user retention and growth drivers.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
iOS + Android app that helps people to track & quit nicotine pouches. Unique design + quality code, not the usual AI slop. I'm ex-snus user so the app is really finetuned based on my actual experience
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.